Kiora Pharmaceuticals (KPRX) Interest Coverage Ratio (2017 - 2022)
Kiora Pharmaceuticals' (KPRX) quarterly Interest Coverage Ratio came in at 763.55 in Q4 2022, up 50.48% on a YoY basis from 507.41 in Q4 2021, and up 80.68% quarter-over-quarter from 3952.01 in Q3 2022.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Interest Coverage Ratio (2017 - 2022) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has reported Interest Coverage Ratio for 6 consecutive years, with 763.55 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Interest Coverage Ratio rose 50.48% year-over-year to 763.55; the trailing twelve-month figure through Dec 2022 stood at 1444.78 (up 30.47% YoY), and the FY2025 full-year result was 642.84, down 405.66% from the prior year.
- Interest Coverage Ratio grew to 763.55 in Q4 2022 per KPRX's latest filing, from 3952.01 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 7672.59 in Q1 2019 and bottomed at 31663.06 in Q3 2019.
- Historically, Interest Coverage Ratio has averaged 6636.82 across 5 years, with a median of 3441.15 in 2021.
- The sharpest annual moves came in 2019 and 2021: Interest Coverage Ratio jumped 198.04% in 2019, then plunged 451.84% in 2021.
- Over 5 years, Interest Coverage Ratio stood at 10453.55 in 2018, then slumped by 202.89% to 31663.06 in 2019, then soared by 99.12% to 279.4 in 2020, then slumped by 451.84% to 1541.87 in 2021, then jumped by 50.48% to 763.55 in 2022.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 763.55, 3952.01, and 1541.87 for Q4 2022, Q3 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -21.24 |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 114.07 |
| 10 | Kiora Pharmaceuticals | 15.75 Mn | 15.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -763.55 |
| Sep 30, 2022 | -3,952.01 |
| Dec 31, 2021 | -1,541.87 |
| Jun 30, 2021 | -1,386.87 |
| Mar 31, 2021 | -2,930.29 |
| Dec 31, 2020 | -279.40 |
| Sep 30, 2019 | -31,663.06 |
| Jun 30, 2019 | -17,312.96 |
| Mar 31, 2019 | 7,672.59 |
| Sep 30, 2018 | -10,453.55 |
| Jun 30, 2018 | -9,204.99 |
| Mar 31, 2018 | -7,825.82 |
| Sep 30, 2017 | -13,618.76 |
| Jun 30, 2017 | -10,907.52 |
| Mar 31, 2017 | -9,635.68 |